Orgenesis Inc. (ORGS)
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.
$5.77M
Ms. Vered Caplan M.Sc.
151.00
Germantown, MD
Jul 01, 2010
-0.15
$-8.00
0.04
0.07
308.41%
-1.06
-0.05
-2.76
-0.40
0.07
-132.15%
312.02%
Similar stocks (11)
Design Therapeutics, Inc.
DSGN
Eliem Therapeutics, Inc.
ELYM
Rezolute, Inc.
RZLT
Acrivon Therapeutics, Inc. Common Stock
ACRV
Aerovate Therapeutics, Inc.
AVTE
AN2 Therapeutics, Inc.
ANTX
NeuroBo Pharmaceuticals, Inc.
NRBO
Indaptus Therapeutics, Inc.
INDP
Lixte Biotechnology Holdings, Inc.
LIXT
Pasithea Therapeutics Corp.
KTTA
Quoin Pharmaceuticals, Ltd.
QNRX
Similar stocks (11)
Design Therapeutics, Inc.
DSGN
Eliem Therapeutics, Inc.
ELYM
Rezolute, Inc.
RZLT
Acrivon Therapeutics, Inc. Common Stock
ACRV
Aerovate Therapeutics, Inc.
AVTE
AN2 Therapeutics, Inc.
ANTX
NeuroBo Pharmaceuticals, Inc.
NRBO
Indaptus Therapeutics, Inc.
INDP
Lixte Biotechnology Holdings, Inc.
LIXT
Pasithea Therapeutics Corp.
KTTA
Quoin Pharmaceuticals, Ltd.
QNRX